NYSE:ELAN | Cash Flow Statement | Elanco Animal Health Inc

Complete source-backed cash-flow history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$54M
2026-03-31$57M$172M$13M$51M-$60M-$65M
2025-12-31-$276M$174M$108M$62M-$64M-$18M
2025-09-30-$34M
2025-06-30$11M
2025-03-31$67M$161M-$4M$65M-$58M$52M
2024-12-31-$8M$164M$177M$47M-$90M-$32M
2024-09-30$364M
2024-06-30-$50M
2024-03-31$32M$166M$2M$24M$37M-$27M
2023-12-31-$141M$171M$157M$41M-$35M-$139M
2023-09-30-$1.1B
2023-06-30-$97M
2023-03-31$103M$173M-$145M$24M-$55M$174M
2022-12-31-$54M$168M$13M$100M-$76M-$84M
2022-09-30-$65M
2022-06-30-$10M
2022-03-31$51M$176M-$62M$19M-$29M-$200M
2021-12-31-$105M$174M$223M$99M-$74M$44M
2021-09-30-$104M
2021-06-30-$210M
2021-03-31-$61M$202M$22M$18M$10M$2M
2020-12-31-$337M$222M-$93M$119M-$74M-$18M
2020-09-30-$135M
2020-06-30-$53M
2020-03-31-$49M$82M$4M$13M-$20M$897M
2019-12-31-$9.4M$82.9M$126.2M$90.2M-$74.5M-$6.4M
2019-09-30$10M
2019-06-30$35.9M
2019-03-31$31.5M$75.2M$8.1M$28M-$31M-$339.5M
2018-12-31$16.4M$73.7M$139.5M$60.2M-$48.1M-$362.4M
2018-09-30$60.2M
2018-06-30-$62.8M
2018-03-31$72.7M$74.3M$47M$32.7M-$34.4M-$76.5M
2017-12-31-$161.5M$87.1M$6.7M$66.9M-$35.5M$4M
2017-09-30-$20.7M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$232M$680M$560M$276M-$279M-$275M
2024-12-31$338M$662M$541M$147M$1.16B-$1.49B
2023-12-31-$1.23B$694M$271M$140M-$169M-$83M
2022-12-31-$78M$682M$452M$171M-$179M-$549M
2021-12-31-$483M$716M$483M$159M-$530M$210M
2020-12-31-$574M$517M-$41M$135M-$4.78B$4.95B
2019-12-31$68M$314M$224M$140M-$235M-$305M
2018-12-31$86.5M$296M$487.3M$134.5M-$127M-$35.2M
2017-12-31-$310.7M$318.4M$173.8M$98.6M-$964.6M$847.5M
2016-12-31-$47.9M$254.4M$155.9M$110.3M-$182.1M-$149.6M